News Tandem secures FDA approval for Control-IQ+ use in pregnancy The approval is based on findings from the CIRCUIT trial published in JAMA in October 2025. Salong Debbarma
News Daiichi and GAIA join forces to commercialise digital cardiovascular therapy Annabel Kartal Allen
News BlueWind’s Revi urinary incontinence device demonstrates three-year efficacy Annabel Kartal Allen